Single nucleotide polymorphisms in CXCR1 gene and its association with hepatitis B infected patients in Saudi Arabia

Annals of Hepatology

Volumn 12, Issue 2, 2013, Pages 220-227

  Almajhdi, Fahad N ^a   Al Ahdal, Mohammed ^b   Abdo, Ayman A ^a   Sanai, Faisal M ^a,c   Al Anazi, Mashael ^b   Khalaf, Nisreen ^b   Viswan, Nisha A ^b   Al Ashgar, Hamad ^b   Al Kahtani, Khalid ^b   Al Humaidan, Hind ^b   Al Swayeh, Riham ^b   Hussain, Zahid ^a   Alarifi, Saud ^a   Al Okail, Majid ^a   Al Qahtani, Ahmed ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

CXCR1; Genetics; Haplotype; Hepatitis B Virus; Saudi Arabia; Single nucleotide polymorphisms; Variations

Indexed keywords

ARTICLE; CONTROLLED STUDY; CXCR1 GENE; DISEASE ACTIVITY; DISEASE COURSE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HETEROZYGOSITY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MISSENSE MUTATION; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS GENE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; MULTICENTER STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK; RISK FACTOR;

CHEMOKINE RECEPTOR CXCR1;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, INTERLEUKIN-8A; RISK FACTORS; SAUDI ARABIA; SEQUENCE ANALYSIS, DNA;

EID: 84885133701     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31360-2     Document Type: Article

References (29)

1. Shapiro C. Epidemiology of hepatitis B. Pediatric Infect Dis J 2010; 12: 433-7.
2. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med 2007; 12: 160-7.
3. Watson RW. The rising incidence of hepatocellular carcinoma. N Engl J Med 1999; 341: 451-2.
4. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, Murthy KK et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003; 302: 659-62.
5. Bowen DG, Walker CM. Mutational escape from CD8+T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 2005; 201: 1709-14.
6. Park BL, Kim YJ, Cheong HS, Kim LH, Choi YH, Lee HS, Shin HD. Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance. Exp Mol Med 2006; 38: 694-702.
7. Durantel D, Zoulim F. Innate response to hepatitis B virus infection: observations challenging the concept of a stealth virus. Hepatology 2009; 50: 1692-5.
8. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992; 267: 16283-87.
9. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1989; 1: 2-13.
10. Bar-Eli M. Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 1999; 67: 12-8.
11. Li A, Dubey S, Varney ML, Singh RK. Interleukin-8 induced proliferation, survival, and MMP production in CXCR1 and CXCR2 expressing human umbilical vein endothelial cells. Microvasc Res 2002; 64: 476-81.
12. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 1996; 93: 6682-6.
13. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 1995; 57: 752-62.
14. Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 2001; 7: 3298-304.
15. Cheong JY, Cho SW, Choi JY, Lee JA, Kim MH, Lee JE, Hahm KB, et al. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. J Korean Med Sci 2007; 22: 529-35.
16. Vasilescu A, Terashima Y, Enomoto M, Heath S, Poonpiriya V, Gatanaga H, Do H, et al. A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients. Proc Natl Acad Sci USA 2007; 104: 3354-9.
17. Stemmler S, Arinir U, Klein W, Rohde G, Hoffjan S, Wirkus N, Reinitz-Rademacher K, et al. Association of interleukin-8 receptor alpha polymorphisms with chronic obstructive pulmonary disease and asthma. Genes Immun 2005; 6: 225-30.
18. Boyton RJ, Reynolds C, Wahid FN, Jones MG, Ozerovitch L, Ahmad T, Chaudhry A, et al. IFN gamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens 2006; 68: 325-30.
19. Renzoni E, Lympany P, Sestini P, Pantelidis P, Wells A, Black C, Welsh K, et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum 2000; 43: 1633-40.
20. Lee KM, Shen M, Chapman RS, Yeager M, Welch R, He X, Zheng T, et al. Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 2007; 28: 1437-41.
21. Zhang W, Stoehlmacher J, Park DJ, Yang D, Borchard E, Gil J, Tsao-Wei DD, et al. Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer. Clin Colorectal Cancer 2005; 5: 124-31.
22. Abdo AA, Karim HA, Al Fuhaid T, Sanai FM, Kabbani M, Al Jumah A, Burak K. Saudi gastroenterology association guidelines for the diagnosis and management of hepatocellular carcinoma: summary of recommendations. Ann Saudi Med 2006; 26: 261-5.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
24. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18: 217-42.
25. Yang H, He XX, Song QL, Chen M, Li J, Wang MY, Yu JL, et al. Association of Ephrin receptor A3 gene polymorphism with susceptibility to chronic severe hepatitis B. Hepatol Res 2012; 42: 790-7.
26. Yan Z, Tan W, Dan Y, Zhao W, Deng C, Wang Y, Deng G. Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population. BMC Med Genet 2012; 24: 49.
27. Song QL, He XX, Yang H, Li J, Chen M, Wang MY, Liu Q, et al. Association of a TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population. Viral Immunol 2012; 25(1): 73-8.
28. Al-Qahtani A, Al-Ahdal M, Abdo A, Sanai F, Al-Anazi M, Khalaf N, Viswan NA, et al. 2012. Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients. J Med Virol 2012; 84(9): 1353-9.
29. Al-Qahtani A, Alarifi S, Al-Okail M, Hussain Z, Abdo A, Sanai F, Al-Anazi M, et al. RANTES gene polymorphisms (-403G>A and-28C>G) associated with hepatitis B virus infection in a Saudi population. Genet Mol Res 2012; 11(2): 855-62.